FDA advisors back new female condom
16th December 2008
A potentially less-costly version of Female Health Company's condom for women won unanimous backing from a U.S. Food and Drug Administration advisory panel on Thursday.
A lower price could attract more users and allow health organizations to distribute more of the condoms to help stem the spread of the virus that causes AIDS, the panel heard.
The panel of experts voted 15-0 to recommend the FDA approve the FC2 Female Condom. The agency usually follows the advice of its advisers.
"This will allow women in general to take even more control of their ability to protect themselves," said Michael Thomas, a panelist from the University of Cincinnati's College of Medicine.
Access the full article here.